Tumor-derived exosomal microRNA-15b-5p augments laryngeal cancer by targeting TXNIP-Reference-Cited by-同舟云学术

Tumor-derived exosomal microRNA-15b-5p augments laryngeal cancer by targeting TXNIP

Published:2022-02-13 Issue:7 Volume:21 Page:730-740
ISSN:1538-4101
Container-title:Cell Cycle
language:en
Short-container-title:Cell Cycle

Author:

Yu Feng¹,Lin Ying¹,Tan Guojie²,Ai Maomao¹,Gong Huicheng²,Liu Wei²,Huang Jiali¹,Zou Zirou¹

Affiliation:

1. Department of Otolaryngology Head and Neck Surgery, Guangzhou Red Cross Hospital, Institute of Otolaryngology Head and Neck Surgery, Jinan University, Guangzhou, China

2. Department of Otolaryngology Head and Neck Surgery, Guangzhou Twelfth People’s Hospital, Guangzhou Medical University, Guangzhou, China

Funder

Science and Technology Commission Project of Guangzhou City

Natural Science Foundation of Guangdong Province

Publisher

Informa UK Limited

Subject

Cell Biology,Developmental Biology,Molecular Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384101.2021.2022845

Reference40 articles.

1. Multidisciplinary Care of Laryngeal Cancer

2. An update on larynx cancer

3. The Treatment of Laryngeal Cancer

4. Tumor-Derived Exosomes and Their Role in Cancer Progression

5. The Emerging Role of Exosomes in Diagnosis, Prognosis, and Therapy in Head and Neck Cancer

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Connection between Radiation-Regulating Functions of Natural Products and miRNAs Targeting Radiomodulation and Exosome Biogenesis;International Journal of Molecular Sciences;2023-08-04

2. Statement of Retraction: Tumor-derived exosomal microRNA-15b-5p augments laryngeal cancer by targeting TXNIP;Cell Cycle;2023-05-25

3. Biological function analysis of miR-15b-5p promoting head and neck tumor development by targeting UGT1A7;2023-05-17

4. Extracellular Vesicles as Biomarkers in Head and Neck Squamous Cell Carcinoma: From Diagnosis to Disease-Free Survival;Cancers;2023-03-17

5. A Comprehensive Review on Function of miR-15b-5p in Malignant and Non-Malignant Disorders;Frontiers in Oncology;2022-05-02